We assessed a cohort of people living with human immunodeficiency virus (PLWH) (n = 110) and HIV negative controls (n = 64) after 1, 2 or 3 SARS-CoV-2 vaccine doses. At all timepoints, PLWH had significantly lower neutralizing antibody (nAb) titers than HIV-negative controls. We also observed a delayed development of neutralization in PLWH that was underpinned by a reduced frequency of spike-specific memory B cells (MBCs). Improved neutralization breadth was seen against the Omicron variant (BA.1) after the third vaccine dose in PLWH but lower nAb responses persisted and were associated with global MBC dysfunction. In contrast, SARS-CoV-2 vaccination induced robust T cell responses that cross-recognized variants in PLWH. Strikingly, individuals with low or absent neutralization had detectable functional T cell responses. These PLWH had reduced numbers of circulating T follicular helper cells and an enriched population of CXCR3+CD127+CD8+T cells after two doses of SARS-CoV-2 vaccination.
Pubmed ID: 36590902 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This unknown targets mouse Ig k
View all literature mentionsThis unknown targets
View all literature mentionsThis monoclonal targets Mouse Human Interferon-gamma ylated clone 7-B6-1
View all literature mentionsThis monoclonal targets Human IFN-?? (Interferon-gamma)
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD25 (IL-2 Receptor α)
View all literature mentionsThis monoclonal targets CD56 (NCAM-1)
View all literature mentionsThis monoclonal targets CD185 (CXCR5)
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets CD45RA
View all literature mentionsThis monoclonal targets CD38
View all literature mentionsThis monoclonal targets CD27
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD197
View all literature mentionsThis monoclonal targets CD14
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD20
View all literature mentionsThis monoclonal targets IgM
View all literature mentionsThis monoclonal targets IgD
View all literature mentionsThis unknown targets Human IgG, Fc? Fragment Specific
View all literature mentionsThis unknown targets Human IgM, Fc5
View all literature mentionsCell line HEK293T/17 is a Transformed cell line with a species of origin Homo sapiens (Human)
View all literature mentions